HIBack of Napkin
Hims & Hers Health, Inc. HIMS
Two quarters ago Hims & Hers grew 3.8% and earned money. Last quarter it grew 38.2% and lost $97.2M at the operating line.
That is not a business having a bad patch. That is a company that decided to buy growth, and the only question worth asking is what it is paying per dollar of it.
HIMS · price with moving averages
Source: market data.
The business
Hims & Hers sells prescription and over-the-counter treatments directly to consumers through a subscription telehealth platform: hair loss, sexual health, dermatology, mental health, and weight. A customer answers questions online, a licensed provider writes the script, and the product arrives at the door monthly. Roughly nine in ten dollars are recurring subscription revenue, which is the reason the model deserved a premium in the first place.
The weight-loss franchise is the swing factor and it has been unstable by design. The business was built on compounded semaglutide sold while the branded drug was in shortage. When the shortage ended, that pathway narrowed, and the company has been rebuilding the category on a different footing ever since, alongside an international push. Everything in the numbers below traces back to that.
Inside the complete Back of Napkin
- 01The business
- 02The numbers
- 03Management
- 04How it fails or surprises you
- 05The shape of the payoff
- 06Closing thoughts
- 07Methodology
Continue with HIMS
Get the complete Back of Napkin free.
Choose this as your free complete report. No card required.
Read the complete reportAlready a member? Sign in


